RPS15AP32

Across TCGA pan-cancer cohorts, RPS15AP32 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RPS15AP32 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RPS15AP32 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS15AP32 expression acts as an unfavorable survival marker.

BRCA, PAAD, and HNSC are the cancer types where RPS15AP32 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	II,III,IV	0.741	0.915	.001	60	view →
PAAD	OS	Tertile	II,III,IV	0.037	0.621	<.001	45	view →
HNSC	OS	Tertile	II,III,IV	0.273	0.715	.016	45	view →
THYM	DFS	Tertile	All	0.111	0.826	<.001	36	view →
LUSC	OS	Tertile	All	0.369	0.740	<.001	30	view →
COAD	DFS	Tertile	All	0.219	0.691	.010	18	view →
GBM	OS	Tertile	All	0.191	0.419	.014	18	view →
OV	OS	Tertile	All	0.748	0.848	.012	12	view →
UCEC	DFS	Tertile	All	0.862	0.898	.019	12	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RPS15AP32–BRCA (OS)

Open the BRCA breakdown →